凯发一触即发

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency.

Mol Neurodegener. 2017; 
AgadjanyanMichael G,ZagorskiKaren,PetrushinaIrina,DavtyanHayk,KazarianKonstantin,AntonenkoMaxim,DavisJoy,BonCharles,Blurton-JonesMathew,CribbsDavid H,GhochikyanAn
Products/Services Used Details Operation
Peptides were synthesized by standard chemical peptide synthesis and purity was analyzed by HPLC (GenScript, NJ).The antibody fragments of VH, VL, CH and CL were amplified according to the standard operating procedure for RACE at GenScript (Genscript, Piscataway, NJ). 1C9 antibody was humanized by Genscript using proprietary technology.High tau protein-binding phages were selected after three rounds of panning using Genscript’s proprietary FASEBA screening methodology. Filtered supernatant was loaded onto Protein A CIP column 65 ml (GenScript, Cat.No.L00433) at 8.0 ml/min. After washing with PBS, elution with 50 mM Citric acid, pH 3.0 and neutralization with 1 M Tris–HCl, pH 9.0, the eluted fractions were desalted by HiPrep 26/10 Desalting column with PBS.96-well plates (Immulux HB; Dynex Technologies, Inc., VA) were coated with 1 μg/well (in 100 μl; Carbonate-Bicarbonate buffer, pH 9.6, o/n at 4 °C) tau2– 18 peptide (GenScript, NJ).

摘要

The experience from clinical trials indicates that anti-Aβ immunotherapy could be effective in early/pre-clinical stages of AD, whereas at the late stages promoting the clearing of Aβ alone may be insufficient to halt the disease progression. At the same time, pathological tau correlates much better with the degree of dementia than Aβ deposition. Therefore, targeting pathological tau may provide a more promising approach for the treatment of advanced stages of AD. Recent data demonstrates that the N-terminal region of tau spanning aa 2-18 termed "phosphatase activation domain" that is normally hidden in the native protein in 'paperclip'-like conformation, becomes exposed in pathological tau and plays... More

关键词

Alzheimer’s disease,Humanization,Immunotherapy,Monoclonal antibody,Phosphatase activation domain,Tauopathy,Therapeutic effi